sr 48692 has been researched along with sgi 1776 in 1 studies
| Studies (sr 48692) | Trials (sr 48692) | Recent Studies (post-2010) (sr 48692) | Studies (sgi 1776) | Trials (sgi 1776) | Recent Studies (post-2010) (sgi 1776) |
|---|---|---|---|---|---|
| 203 | 3 | 36 | 59 | 0 | 56 |
| Protein | Taxonomy | sr 48692 (IC50) | sgi 1776 (IC50) |
|---|---|---|---|
| Tyrosine-protein kinase Yes | Homo sapiens (human) | 1.455 | |
| Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | 0.0158 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.007 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.362 | |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | 0.0382 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.069 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.8727 | |
| Serine/threonine-protein kinase pim-3 | Homo sapiens (human) | 0.0659 | |
| Serine/threonine-protein kinase haspin | Homo sapiens (human) | 0.034 | |
| Serine/threonine-protein kinase pim-2 | Homo sapiens (human) | 0.4053 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
1 other study(ies) available for sr 48692 and sgi 1776
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |